South Dakota Investment Council Raises Stake in Teleflex Incorporated (NYSE:TFX)

South Dakota Investment Council increased its stake in Teleflex Incorporated (NYSE:TFX) by 16.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,230 shares of the medical technology company’s stock after acquiring an additional 1,300 shares during the quarter. South Dakota Investment Council’s holdings in Teleflex were worth $1,643,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Janus Henderson Group PLC increased its position in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the period. FMR LLC grew its stake in Teleflex by 70.1% in the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. raised its position in Teleflex by 31.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares in the last quarter. Parkman Healthcare Partners LLC purchased a new stake in shares of Teleflex in the 3rd quarter worth $23,778,000. Finally, Ceredex Value Advisors LLC grew its position in shares of Teleflex by 64.6% during the 3rd quarter. Ceredex Value Advisors LLC now owns 199,975 shares of the medical technology company’s stock worth $49,458,000 after buying an additional 78,500 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Trading Up 0.2 %

NYSE TFX opened at $175.43 on Monday. The firm has a market cap of $8.15 billion, a PE ratio of 34.88, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 52 week low of $165.62 and a 52 week high of $249.90. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a 50 day moving average price of $176.98 and a 200 day moving average price of $207.23.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on TFX shares. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Royal Bank of Canada lowered their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Truist Financial cut their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.